KeyCorp Investing Cash Flow decreased by 290.9% to -$4.59B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 545.9%, from -$711.00M to -$4.59B. Over 3 years (FY 2021 to FY 2024), Investing Cash Flow shows an upward trend with a -46.2% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$4.58B | -$5.96B | $0.00 | $1.97B | -$6.15B | -$6.17B | -$583.00M | -$7.34B | $1.92B | $6.24B | $592.00M | $374.00M | $658.00M | $272.00M | $1.19B | -$711.00M | $2.73B | $2.41B | -$4.59B |
| QoQ Change | — | -29.9% | +100.0% | — | -411.6% | -0.4% | +90.6% | <-999% | +126.2% | +224.8% | -90.5% | -36.8% | +75.9% | -58.7% | +338.6% | -159.6% | +483.7% | -11.8% | -290.9% |
| YoY Change | — | — | — | — | -34.2% | -3.7% | — | -471.6% | +131.2% | +201.1% | +201.5% | +105.1% | -65.7% | -95.6% | +101.5% | -290.1% | +314.6% | +101.6% | -545.9% |